Tumor Lysate Particle Only Vaccine (TLPO) Vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa Trial
CANCER TREATMENT AND RESEARCH COMMUNICATIONS(2024)
Key words
Cancer vaccine,Melanoma,Dendritic cell,Immunotherapy,Personalized medicine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined